Document is current
Any future updates will be listed below
-
Authors
Gorgy, George https://orcid.org/0009-0006-0961-4975
Avrumova, Fedan https://orcid.org/0000-0003-3760-8776
Paschal, Philip K. https://orcid.org/0000-0003-3109-7397
Paschal, Gregory K. https://orcid.org/0009-0005-6153-5679
Carrino, John A. https://orcid.org/0000-0003-3472-2469
Lebl, Darren R. https://orcid.org/0000-0003-2890-5795
- License Information
-
More Information
Article History
Received: 14 August 2023
Accepted: 10 December 2023
First Online: 8 February 2024
Declarations
:
: GG, FA, PKP, and GKP do not have any conflicts of interest to disclose. JAC reports being a Governing Board Member for the American College of Rheumatology (ACR), the International Society of Osteoarthritis Imaging, and the Radiology Society of North America. JAC reports to be a consultant for AstraZeneca, Covera Health, Eli Lilly & Company, Globus Medical, Inc., Pfizer, and Regeneron Pharmaceuticals, Inc. DRL reports royalties from Stryker, royalties from NuVasive, ownership interest from Woven Orthopedic Technologies, ownership interest from Viseon, Inc, ownership interest from Vestia Ventures MiRus Investment LLC, ownership interest from ISPH II, LLC, ownership interest from HS2, LLC, ownership interest from Remedy Logic, on the advisory board for Remedy Logic, on the advisory board for Choice Spine, a consultant for Choice Spine, a consultant for Depuy Synthes and a consultant for Viseon, Inc outside the submitted work.
: Ethical approval was obtained from the Institutional Review Board at the Hospital for Special Surgery (IRB#2019-1402). The study was conducted in accordance with the Declaration of Helsinki. Approval was granted by the Ethics Committee at the Hospital for Special Surgery (2019-1402).
: The participants did not need to give informed consent in addition to routine informed consent procedures.
